Mangoceuticals Inc. purchased patents from Intramont Technologies for $20 million, paying with shares and cash, and amended the agreement to credit development costs against future payments, with $306,118 remaining due. Additionally, the company sold shares for $350,000 and exercised warrants for 240,000 shares at $1.50 each.